Proin for Dogs: Uses, Doses, and Side Effects

By Dr. Zubair Khalid, DVM, MS, PhD ·

Proin for Dogs: Uses, Doses, and Side Effects

Proin is a veterinary brand of phenylpropanolamine, a prescription alpha-1 adrenergic agonist that tightens the urethral sphincter so urine stays in the bladder. It is used to treat urethral sphincter mechanism incompetence (USMI), the leaky-urethra condition that causes most involuntary urine leakage in spayed female dogs. Proin is not a treatment for urinary tract infection, ectopic ureter, bladder stones, or neurologic incontinence, and it is not a weight-loss drug for dogs or people. This guide covers how phenylpropanolamine works, the labeled weight-based dose range, the side effects owners actually see, and a practical monitoring plan you can bring to your veterinarian.

This article is educational and is not a substitute for veterinary diagnosis or treatment.

At a Glance

FeatureDetail
Active ingredientPhenylpropanolamine hydrochloride
Drug classAlpha-1 adrenergic agonist (sympathomimetic)
Brand nameProin (also sold as generic phenylpropanolamine)
SpeciesDogs
Labeled useManagement of urethral sphincter mechanism incompetence
FormChewable tablet
How it is givenBy mouth, usually two to three times daily
Typical labeled dose range1.1 to 2.2 mg/kg per dose (about 0.5 to 1 mg/lb)
Onset of effectUrethral pressure rises within a few hours of a dose
Duration per doseRoughly 8 to 12 hours, which is why dosing is often split
Prescription statusPrescription only in the United States
Not forUrinary tract infection, ectopic ureter, bladder stones, neurologic causes, weight loss

What Proin Is and What It Treats

Proin is the trade name most US veterinarians use for phenylpropanolamine, a sympathomimetic amine that has been used in veterinary urinary medicine for decades. The FDA-approved label indication is the management of urethral sphincter mechanism incompetence in dogs. That is a specific diagnosis, not a synonym for "leaking urine." USMI means the urethral sphincter, the muscular valve that holds urine in the bladder between trips outside, is too weak to do its job. The bladder itself is usually normal, and the dog usually urinates normally when let out. The problem is what happens between those trips.

Phenylpropanolamine was shown to be effective and safe in dogs with primary sphincter incompetence in a classic study of 11 female and 8 male dogs. Before treatment, those dogs had significantly lower maximal urethral closure pressures than normal dogs. After treatment, maximal urethral closure pressure rose into the normal range in both sexes, and incontinence resolved clinically in all but one male and one female, with those two improving considerably [1]. That study remains the clearest demonstration of why the drug works: it does not fix the bladder, it restores sphincter tone.

USMI is most common in spayed female dogs. An international survey of Spanish and Italian veterinarians found that urethral sphincter mechanism incompetence is the leading diagnosis in incontinent female dogs, and phenylpropanolamine was the first-choice medical treatment in both countries [2]. A retrospective study of 163 neutered female dogs with USMI found the condition is most common in dogs weighing more than 20 kg, and the median time from spay to the first episode of incontinence was 3.73 years. Phenylpropanolamine was prescribed in 75.5% of those dogs [3]. USMI is uncommon in male dogs, and when it does occur in males it tends to respond less well to medical therapy [4].

How Phenylpropanolamine Works

Dog urinary bladder specimen labeled Canis lupus familiaris
Proin works on the urethral sphincter of the dog bladder to reduce urine leakage in USMI. Image: Wagner Souza e Silva, CC BY-SA 4.0, via Wikimedia Commons.

Phenylpropanolamine is an alpha-1 adrenergic agonist. Alpha-1 receptors sit on the smooth muscle of the internal urethral sphincter and the proximal urethra. When phenylpropanolamine binds those receptors, the smooth muscle contracts, the urethral lumen narrows, and the pressure needed to keep urine in the bladder rises. In practical terms, the drug gives the sphincter a mechanical assist.

The urodynamic evidence is consistent. In continent female dogs given a single oral dose of phenylpropanolamine at 1.5 mg/kg, urethral pressures increased over four to six hours and functional urethral length increased two to six hours after dosing. Arterial blood pressure rose at four to six hours and was compensated by a fall in heart rate over twelve hours [5]. In a pharmacokinetic and urodynamic study in female Beagles, peak plasma concentration was reached about two hours after an oral dose, and the half-life was roughly four hours. Three-times-daily dosing caused drug accumulation and higher peak concentrations [6]. That short half-life is the reason most dogs are dosed more than once a day rather than once.

The same alpha-1 activity that tightens the urethra also tightens blood vessels elsewhere in the body. That is the source of most of the drug's side effects, and it is why blood pressure monitoring matters in dogs on long-term therapy.

Diagnosing USMI Before Starting Proin

Phenylpropanolamine is a treatment, not a diagnostic test. Starting it before a workup can mask a serious problem or waste months on a drug that was never going to work. A 2025 case report described a 16-month-old spayed female miniature poodle with USMI that was refractory to maximal doses of phenylpropanolamine and estriol. The dog had blood work, urinalysis, urine culture and sensitivity, ultrasound, cystoscopy, and contrast abdominal CT. The eventual diagnosis was lower back pain, and after manual therapy, acupuncture, and photobiomodulation, the dog became continent within two days and stayed continent 99.4% of days after all medications were discontinued [7]. That case is a reminder that not every leaky dog has a primary sphincter problem.

Rule Out Urinary Tract Infection First

A urine sample for urinalysis and culture is the first step in almost every incontinent dog. Infection, inflammation, and crystalluria can all cause or worsen leakage, and none of them respond to phenylpropanolamine. In one case report, a 2-year-old beagle presented for inappropriate urination and was found to have cystitis, which resolved with antibiotics. The incontinence persisted after the infection cleared, and the dog was then treated successfully for the underlying sphincter problem [8]. Treating infection first, then reassessing, is standard practice.

Rule Out Ectopic Ureter and Anatomic Causes

Young dogs, especially females, that have leaked since puppyhood may have an ectopic ureter, meaning one or both ureters bypass the bladder and empty into the urethra or vagina. A 1-year-old spayed French Bulldog with a partial response to phenylpropanolamine was found on cystourethroscopy and retrograde ureteropyelogram to have a duplex left renal system with an extramural ectopic ureter, plus a dual vagina. Surgical reimplantation of the ureter was required [9]. Phenylpropanolamine can reduce leakage in these dogs, which is exactly why a partial response should not be mistaken for a confirmed USMI diagnosis. Imaging is needed.

Rule Out Neurologic Causes

Neurologic disease can produce incontinence that looks like USMI but has a different cause and a different treatment. The 2025 case report linking lower back pain to refractory incontinence is the clearest published example [7]. A dog with spinal pain, weakness, an abnormal gait, or a change in tail or anal tone needs a neurologic assessment before or alongside urinary diagnostics.

Confirm the Diagnosis

Veterinarians commonly use a diagnostic algorithm built from history, physical exam, blood work, urinalysis, and abdominal ultrasound. The international survey found that most diagnoses were made this way, and that urethral pressure measurement was rarely performed (0.2% in Spain and 2.4% in Italy) [2]. Advanced imaging such as contrast radiology, CT urography, and cystoscopy is used when the history or the response to treatment does not fit simple USMI.

Proin Dosing for Dogs

Proin is a chewable tablet given by mouth. The FDA-approved label dose range is 1.1 to 2.2 mg/kg per dose, which works out to roughly 0.5 to 1 mg per pound of body weight per dose. Dosing frequency is typically two to three times daily. Your veterinarian sets the exact dose and schedule based on your dog's weight, response, and tolerance.

Weight-Based Dosing Table

The table below converts the labeled 1.1 to 2.2 mg/kg range into milligrams per dose for common body weights. It is a reference for understanding your prescription, not a substitute for the dose your veterinarian writes. Proin chewable tablets are scored so doses can be split, and tablets come in several strengths.

Body weightBody weightLow end (1.1 mg/kg)High end (2.2 mg/kg)
5 lb2.3 kg2.5 mg5 mg
10 lb4.5 kg5 mg10 mg
15 lb6.8 kg7.5 mg15 mg
20 lb9.1 kg10 mg20 mg
30 lb13.6 kg15 mg30 mg
40 lb18.2 kg20 mg40 mg
50 lb22.7 kg25 mg50 mg
60 lb27.3 kg30 mg60 mg
75 lb34.1 kg37.5 mg75 mg
100 lb45.5 kg50 mg100 mg

Doses in the table are per dose, not per day. A 40 lb dog at the middle of the range might receive 30 mg two to three times daily, which is 60 to 90 mg per day. Always confirm the total daily dose with your veterinarian.

Tapering to the Lowest Effective Dose

Phenylpropanolamine is not usually started at the top of the range and left there forever. Clinical practice is to find the lowest dose that keeps the dog dry. A field trial in spayed bitches found that an initial phenylpropanolamine dose of 1.5 mg/kg twice daily was highly effective (97% of dogs) with very few side effects, and the authors recommended reducing the dose step by step to the lowest amount that maintained continence [10]. A separate study used either 1 mg/kg three times daily or 2 mg/kg once daily in a prolonged-release formulation, and incontinence resolved in all ten bitches, with improvement maintained for one to more than two years in nine of them [11].

The practical takeaway is that your veterinarian may start at a dose in the labeled range, confirm the dog is dry, then reduce the dose in steps over weeks. If leakage returns at a lower dose, the previous dose is restored. This taper is why follow-up matters more than the starting number.

What to Do If You Miss a Dose

Give the missed dose when you remember if it is close to the scheduled time. If it is almost time for the next dose, skip the missed dose and resume the normal schedule. Never give two doses at once to catch up. Doubling a dose of an alpha-1 agonist can cause a sharp rise in blood pressure and marked restlessness.

What to Do After a Wet Episode

A single wet episode does not mean the dose should be increased, and it never means you should double the next dose. Leakage can happen for many reasons: a longer-than-usual gap between doses, a big drink of water, excitement, a full bladder after a nap, or a urinary tract infection. Write down the date, time, and circumstances, and call your veterinarian. Dose changes should come from your veterinarian, not from a bad day.

Side Effects of Proin in Dogs

Most dogs tolerate phenylpropanolamine well. The classic study of 19 dogs with primary sphincter incompetence reported minimal side effects and no change in mean arterial blood pressure during treatment [1]. The field trial in spayed bitches reported very few side effects at 1.5 mg/kg twice daily [10]. That said, side effects do occur, and owners should know what to watch for.

Restlessness and Agitation

Restlessness is the most common owner-reported side effect. Phenylpropanolamine is a stimulant-type drug, and some dogs become pacing, panting, or unable to settle after a dose. In a 30-day study of healthy dogs given phenylpropanolamine at 1.1 mg/kg every eight hours, the only variable that differed significantly between groups was pulse rate, which was lower in treated dogs during the first ten days. Signs of illness appeared in a few dogs but were not clearly linked to treatment [12]. If your dog becomes persistently agitated on Proin, tell your veterinarian. A dose reduction often solves it.

Hypertension and Blood Pressure Changes

Phenylpropanolamine raises blood pressure as part of how it works. In continent female dogs given a single 1.5 mg/kg dose, arterial blood pressure rose at four to six hours and heart rate fell over twelve hours as compensation [5]. In another study, diastolic and mean arterial pressures increased significantly during treatment periods [13]. In most dogs this is a controlled, transient effect. In dogs with pre-existing heart disease, kidney disease, or hypertension, it can matter more, and long-term monitoring is warranted.

Cardiac Changes with Long-Term Use

A case report described a 9-year-old spayed Dalmatian treated with phenylpropanolamine for almost 8.5 years who developed a ventricular tachyarrhythmia and severe left ventricular hypertrophy. The arrhythmia was controlled with sotalol, and the hypertrophy almost completely resolved five months after phenylpropanolamine was discontinued. When the drug was restarted at a lower dose, the dog became hypertensive and the hypertrophy recurred [14]. This is a single case, not proof that every dog on long-term Proin will develop heart changes, but it is the reason veterinarians periodically reassess blood pressure and heart health in dogs on chronic therapy.

Anorexia and Appetite Loss

Reduced appetite is a recognized side effect. One bitch inadvertently treated at 2.5 mg/kg, above the labeled range, showed lethargy and inappetence and returned to normal when the dose was reduced [11]. If your dog stops eating or becomes unusually quiet on Proin, that is a reason to call your veterinarian rather than wait.

Rare Tremors and Other Neurologic Signs

Tremors are uncommon but reported. Any new tremor, wobbliness, head tilt, or seizure-like activity in a dog on phenylpropanolamine should be treated as urgent. Stop the drug only on veterinary advice, and call your veterinarian or an emergency clinic the same day.

What to Do If You See Side Effects

Mild restlessness or a single skipped meal in the first few days may settle. Persistent agitation, vomiting, a marked drop in appetite, a new tremor, collapse, or a rapid or irregular heartbeat warrants a call to your veterinarian. Do not adjust the dose on your own. Bring the bottle with you so the exact strength and dose can be reviewed.

Dogs That Should Not Receive Proin

Phenylpropanolamine is a prescription drug, and your veterinarian will weigh the risks before prescribing it. Conditions that require caution include:

  • Known heart disease, arrhythmias, or a heart murmur
  • Pre-existing hypertension
  • Kidney disease or other conditions where blood pressure control is fragile
  • Glaucoma, since sympathomimetics can raise intraocular pressure
  • Hyperthyroidism
  • Diabetes mellitus, since sympathomimetics can affect glucose handling
  • Concurrent use of monoamine oxidase inhibitors or other sympathomimetics
  • Pregnancy or breeding, since safety has not been established in breeding dogs

Tell your veterinarian every medication, supplement, and compounded product your dog receives. Phenylpropanolamine has been studied in combination with selegiline in healthy dogs without major interactions [12], and it is commonly combined with estrogens such as estriol or diethylstilbestrol in dogs that do not respond fully to one drug [15]. Combination therapy is a decision for your veterinarian.

Monitoring Your Dog on Proin

Monitoring is where owners add the most value. Your veterinarian can measure blood pressure and listen to the heart, but only you see how often the dog leaks and how the dog behaves at home. Bring written records to every recheck.

Frequency of Leakage

Track wet episodes by date, time, and situation. Note whether the dog was asleep, excited, or had just drunk a lot of water. A dog that leaks every night is different from a dog that leaks once a week after a long nap. This record is what your veterinarian uses to decide whether to adjust the dose.

Blood Pressure

Blood pressure should be checked at rechecks, especially in older dogs or dogs with heart or kidney disease. The single-dose study showed a measurable rise in arterial pressure at four to six hours after dosing [5], and the long-term case report linked chronic use to hypertension and cardiac changes [14]. Ask your veterinarian how often blood pressure should be rechecked for your dog.

Behavior Changes

Note restlessness, pacing, panting, changes in sleep, appetite, or activity level. Behavior changes are the most common reason owners stop the drug, and they are also the easiest to miss because they creep in slowly. A simple daily note in a phone app is enough.

Suggested Monitoring Schedule

What to trackHow oftenWhat to record
Wet episodesDailyDate, time, situation, volume
BehaviorDailyRestlessness, appetite, sleep, activity
Body weightMonthlyWeight in pounds or kilograms
Blood pressureAt each recheck, or as directedSystolic and diastolic values
Heart rate and rhythmAt each recheckAny murmur, arrhythmia, or rate change
Urine checkAt each recheck or if leakage worsensUrinalysis and culture if infection is suspected
Medication reviewAt each recheckDose, frequency, missed doses, side effects

The international survey found that veterinarians typically review incontinent dogs after the first week of treatment and then at periodic intervals [2]. Your veterinarian will set a schedule that fits your dog, but a first recheck within one to two weeks of starting treatment is common.

Proin Compared with Other Treatments for USMI

Phenylpropanolamine is the first-line drug for USMI in most practices. The international survey found it was the first-choice medical treatment in both Spain and Italy, ahead of ephedrine and deslorelin [2]. The field trial in spayed bitches found phenylpropanolamine effective in 97% of dogs and ephedrine in 93%, with very few side effects for either, and the authors preferred alpha-sympathomimetics over estrogens for their effectiveness and tolerability [10].

Estrogens such as estriol and diethylstilbestrol are the main alternative or add-on. A study in intact and spayed female Beagles found that estriol alone increased maximal urethral pressure and closure pressure at day seven, but the effect decreased by day fourteen even when phenylpropanolamine was added [15]. In practice, estrogens are often used when phenylpropanolamine alone is not enough, or when the dog cannot tolerate an adequate phenylpropanolamine dose. Compounded diethylstilbestrol has been used successfully in dogs when the commercial product was unavailable [8].

Gonadotropin-releasing hormone analogs are a third option. In 13 ovariectomized incontinent dogs that were refractory to alpha-adrenergics or had a contraindication to them, treatment with leuprolide, deslorelin, buserelin, or triptorelin produced continence for 50 to 738 days in seven dogs treated with the GnRH analog alone. In the remaining dogs, adding phenylpropanolamine restored complete continence for 21 to 367 days [16].

Surgical options exist for dogs that fail medical therapy. These include artificial urethral sphincter placement, urethral bulking injections, and transobturator vaginal tape. A study of transobturator vaginal tape in seven incontinent female dogs found all were continent immediately after the procedure, one recurred at two months and was managed with phenylpropanolamine, and six of seven were continent at a mean follow-up of 11.3 months [17]. An artificial urethral sphincter was used successfully in a 5-month-old dog with incontinence after inadvertent prostatectomy that did not respond to phenylpropanolamine and estriol [18], and in eight male dogs with urethral diverticulum that were poorly or moderately responsive to phenylpropanolamine [19]. Teflon injection into the urethral submucosa achieved continence in all 22 dogs in an older study, though 64% recurred and most were controlled with a second injection [20].

The pattern across all of these studies is the same. Phenylpropanolamine is the starting point. When it works, it works well and can be tapered. When it does not, the next step is usually a change in drug, a dose change, or a surgical referral.

Questions to Ask Your Veterinarian

Bring these to your next appointment:

  1. What diagnosis are we treating, and what tests confirmed it?
  2. What dose and frequency are you prescribing, and what is the total daily dose?
  3. How soon should I expect improvement?
  4. What side effects should make me call you right away?
  5. How often should we recheck blood pressure, urine, and heart function?
  6. Can we try tapering to a lower dose once my dog is dry?
  7. Are there other medications or conditions that make Proin a poor choice for my dog?
  8. What is the plan if Proin does not control the leakage?

Limitations and When to Contact a Veterinarian

This guide covers the general use of phenylpropanolamine in dogs. Every dog is different, and individual cases need a veterinarian who can examine the dog, review the history, and run the appropriate tests. Do not start, stop, or change a Proin dose based on this article.

Contact your veterinarian promptly if any of the following occur:

  • Leakage does not improve within the expected time frame after starting treatment
  • Leakage worsens, or new symptoms appear such as straining to urinate, blood in the urine, or accidents in a previously dry dog
  • Your dog becomes persistently restless, agitated, or unable to settle
  • Your dog stops eating, vomits repeatedly, or becomes lethargic
  • You see tremors, wobbliness, collapse, or seizure-like activity
  • Your dog develops a rapid, irregular, or very slow heartbeat
  • Your dog's gums become pale or your dog seems weak
  • You accidentally give an extra dose or the dog eats the bottle

Call an emergency veterinary clinic immediately for tremors, collapse, seizure-like activity, or a suspected overdose. Phenylpropanolamine is a stimulant, and overdose can cause severe hypertension, cardiac arrhythmias, and neurologic signs.

Frequently Asked Questions

What is Proin used for in dogs?

Proin is used to treat urethral sphincter mechanism incompetence, the leaky-urethra condition that causes most involuntary urine leakage in spayed female dogs. It tightens the urethral sphincter so urine stays in the bladder between trips outside.

How is Proin dosed for dogs?

The FDA-approved label dose is 1.1 to 2.2 mg/kg per dose, given two to three times daily. Your veterinarian sets the exact dose and often tapers it to the lowest amount that keeps your dog dry.

How long does Proin take to work?

Urethral pressure rises within a few hours of a dose, and most owners see improvement within the first few days. The international survey found veterinarians typically review incontinent dogs after the first week of treatment.

What are the most common side effects of Proin in dogs?

Restlessness and agitation are the most common owner-reported side effects. Anorexia, hypertension, and rare tremors are also reported. Most dogs tolerate the drug well at labeled doses.

Can I double the dose if my dog has an accident?

No. Never double a dose after a wet episode. A single accident can happen for many reasons, and doubling an alpha-1 agonist can cause a sharp rise in blood pressure and marked restlessness. Record the episode and call your veterinarian.

Is Proin safe for long-term use in dogs?

Many dogs take Proin for years without problems, but long-term use has been linked in one case report to hypertension and cardiac changes. Periodic blood pressure and heart checks are reasonable for dogs on chronic therapy.

Can Proin be used for weight loss in dogs?

No. Phenylpropanolamine is not a weight-loss drug for dogs. Its labeled veterinary use is urethral sphincter mechanism incompetence. Human weight-loss products containing phenylpropanolamine are not appropriate for dogs and should never be given.

What should I do if my dog has a bad reaction to Proin?

Call your veterinarian the same day for persistent restlessness, appetite loss, vomiting, or lethargy. Call an emergency clinic immediately for tremors, collapse, seizure-like activity, or a suspected overdose. Do not change the dose on your own.

Related Articles

Sources

  1. Clinical response and urethral pressure profile changes after phenylpropanolamine in dogs with primary sphincter incompetence.
  2. An international survey on canine urinary incontinence: case frequency, diagnosis, treatment and follow-up.
  3. Urethral Sphincter Mechanism Incompetence in 163 Neutered Female Dogs: Diagnosis, Treatment, and Relationship of Weight and Age at Neuter to Development of Disease.
  4. Urethral sphincter mechanism incompetence in male dogs: a retrospective analysis of 54 cases.
  5. Urodynamic and haemodynamic effects of a single oral administration of ephedrine or phenylpropanolamine in continent female dogs.
  6. Combined pharmacokinetic and urodynamic study of the effects of oral administration of phenylpropanolamine in female Beagle dogs.
  7. Treatment of lower back pain to resolve symptoms of canine urethral sphincter mechanism incontinence.
  8. Medical therapy for acquired urinary incontinence in dogs.
  9. Urinary incontinence in a dog with a duplex renal system and extramural ectopic ureter.
  10. [[Urinary incontinence in castrated female dogs. 2. Therapy].](https://pubmed.ncbi.nlm.nih.gov/8578574/)
  11. Phenylpropanolamine: an alpha-adrenergic agent for the management of urinary incontinence in the bitch associated with urethral sphincter mechanism incompetence.
  12. Effects of selegiline, phenylpropanolamine, or a combination of both on physiologic and behavioral variables in healthy dogs.
  13. Evaluation of the urodynamic and hemodynamic effects of orally administered phenylpropanolamine and ephedrine in female dogs.
  14. Myocardial hypertrophy associated with long-term phenylpropanolamine use in a dog.
  15. Urodynamic and morphologic changes in the lower portion of the urogenital tract after administration of estriol alone and in combination with phenylpropanolamine in sexually intact and spayed female dogs.
  16. The effect of GnRH analogs on urinary incontinence after ablation of the ovaries in dogs.
  17. Transobturator vaginal tape inside out for treatment of urethral sphincter mechanism incompetence: preliminary results in 7 female dogs.
  18. Placement of an artificial urethral sphincter for treatment of passive urinary incontinence after inadvertent prostatectomy and balloon dilation treatment for stricture formation in a 5-month-old dog.
  19. Placement of an artificial urethral sphincter in 8 male dogs with urethral diverticulum.
  20. Treatment of urinary incontinence in dogs by endoscopic injection of Teflon.